Global Poloxamer Market By Grade(Poloxamer 68, Poloxamer 88, Poloxamer 98, Poloxamer 108, Poloxamer 124, Poloxamer 188, Poloxamer 237, Poloxamer 338, Poloxamer 407), By Method(Direct Solubilization, Thin Film methods, Temperature-induced emulsification), By Application(Biotechnological Activity, Brain Injury Treatment, DNA Delivery, Microbiological Activity, Cardiovascular Treatment, Others), By End-Use(Pharmaceutical Industry, Biotechnological Companies, Research Centers, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033
- Published date: June 2024
- Report ID: 121044
- Number of Pages: 293
- Format:
- keyboard_arrow_up
Quick Navigation
Report Overview
The Global Poloxamer Market size is expected to be worth around USD 59.9 Billion by 2033, From USD 31.6 Billion by 2023, growing at a CAGR of 6.6% during the forecast period from 2024 to 2033.
The Poloxamer Market comprises a niche yet crucial segment within the pharmaceutical and cosmetic industries. Poloxamers, also known as pluronic and polox, are non-ionic triblock copolymers recognized for their unique thermoreversible gelation properties. These substances are integral in formulating a variety of products, including drug delivery systems, skincare, and cleaning agents.
As this market evolves, executives and product managers must consider its impact on enhanced solubility and stability of bioactive compounds, which can drive innovation in product development and improve competitive advantage in both healthcare and personal care sectors.
The global market for poloxamers is witnessing significant growth, driven by diverse applications across the pharmaceutical and biotechnology sectors. Poloxamer 188, for example, plays a crucial role in enhancing the stability of cationic nanoparticles, which is pivotal for augmenting the biological activity of bioactive compounds such as Aloe perryi.
This application is particularly vital as it supports the delivery and efficacy of bioactive compounds in medical treatments and product formulations, providing substantial value to the biopharmaceutical industry. Moreover, Poloxamer 407 is increasingly utilized as a base for mucoadhesive gels, leveraging its antimicrobial properties to broaden its use in medical applications, including wound care and drug delivery systems.
This versatility in applications underscores the compound’s utility in critical healthcare solutions, promoting sustained investment and research in its varied uses. The ongoing research and development in poloxamer applications are likely to unlock new market opportunities and drive further innovation.
As such, stakeholders in the healthcare and pharmaceutical industries are advised to monitor developments within this market closely. Strategic investments in this sector could yield significant returns, given the expanding scope of applications and the rising demand for advanced pharmaceutical ingredients. Market participants should consider partnerships or collaborations that enhance their capabilities in utilizing poloxamers for complex formulations to maintain a competitive edge in this dynamic market.
Key Takeaways
- Market Growth: The Global Poloxamer Market size is expected to be worth around USD 59.9 Billion by 2033, From USD 31.6 Billion by 2023, growing at a CAGR of 6.6% during the forecast period from 2024 to 2033.
- Regional Dominance: The North American Poloxamer market holds a 46.3% share, valued at USD 13.0 billion.
- Segmentation Insights:
- By Grade: Poloxamer 68 accounts for 34.3% of the market share.
- By Method: The direct solubilization method holds 44.7% of the market share.
- By Application: Biotechnological activity constitutes 47.1% of the application market.
- By End-Use: The pharmaceutical industry comprises 45.3% of the market end-use.
- Growth Opportunities: In 2023, the global Poloxamer market will benefit from advancements in drug delivery formulations and eco-friendly production methods, enhancing product efficacy, sustainability, and market demand across various industries.
Driving Factors
Increased Demand for Effective Pharmaceutical Formulations
The growth of the Poloxamer Market is significantly driven by the increased demand for effective pharmaceutical formulations. Poloxamers, known for their excellent solubilizing properties, are extensively utilized in the pharmaceutical industry to enhance the bioavailability and stability of drugs. As the global pharmaceutical market continues to expand, driven by rising healthcare needs and the development of new therapeutics, the demand for poloxamers is witnessing a parallel increase.
These copolymers are particularly valued in the formulation of drug delivery systems, such as injectable solutions, topical formulations, and controlled-release systems, which require reliable solubilization and stabilization capabilities. The ability of poloxamers to improve the efficacy and safety of pharmaceuticals by facilitating better drug absorption and distribution positions them as a critical component in advanced drug formulations. This, in turn, fuels the market growth as pharmaceutical companies increasingly incorporate poloxamers into their product development pipelines.
Growing Need for High-quality Personal Care Products
Another pivotal factor contributing to the expansion of the Poloxamer Market is the growing need for high-quality personal care products. Poloxamers are extensively used in the personal care industry due to their surfactant properties, which make them ideal for formulations such as shampoos, conditioners, skincare products, and cosmetics. The rising consumer preference for premium and multifunctional personal care products, driven by increasing awareness of personal grooming and hygiene, has spurred the demand for high-quality ingredients like poloxamers.
These compounds are favored for their ability to enhance the texture, stability, and performance of personal care products. Additionally, the trend towards natural and mild formulations has led to the increased adoption of poloxamers, which are known for their non-irritating and gentle nature. As consumers seek products that deliver superior sensory experiences and efficacy, manufacturers are incorporating poloxamers to meet these expectations, thereby driving market growth. The convergence of these trends underscores the vital role of poloxamers in the personal care sector, further bolstering their market demand.
Restraining Factors
Limited Thermal Stability
The growth of the Poloxamer Market is notably hindered by the limited thermal stability of poloxamers. These amphiphilic block copolymers, while effective in various applications, exhibit a significant drawback when exposed to high temperatures. Thermal instability can lead to the breakdown of the polymer structure, adversely affecting the performance and efficacy of poloxamer-containing formulations. This is particularly concerning in industries such as pharmaceuticals and personal care, where products are often subjected to varying temperature conditions during manufacturing, storage, and transportation.
The inability of poloxamers to maintain their integrity at elevated temperatures restricts their use in certain formulations, thereby limiting market growth. Manufacturers must invest in additional stabilization measures or alternative materials, which can increase production costs and complexity. As a result, the thermal stability issue poses a significant challenge to the widespread adoption and market expansion of poloxamers.
Susceptibility to Degradation
Susceptibility to degradation further restrains the growth of the Poloxamer Market. Poloxamers are prone to oxidative and hydrolytic degradation, which can compromise their functional properties over time. This degradation can lead to reduced effectiveness in drug delivery systems and personal care products, where long-term stability is crucial. The degradative tendencies of poloxamers necessitate rigorous formulation strategies to enhance their stability, which can complicate the product development process and increase costs.
Moreover, the potential for degradation limits the shelf life of poloxamer-based products, posing challenges in meeting consumer and regulatory standards for product longevity. This issue is particularly critical in the pharmaceutical industry, where the stability of excipients directly impacts the safety and efficacy of medications. The combined impact of thermal instability and susceptibility to degradation underscores the need for advancements in polymer science to develop more robust alternatives or improved stabilization techniques for poloxamers, thereby addressing these restraining factors and fostering market growth.
By Grade Analysis
Poloxamer 68 holds a significant market share, constituting 34.3% of the overall grade distribution.
In 2023, Poloxamer 68 held a dominant market position by Grade segment of the Poloxamer Market, capturing more than a 34.3% share. The market values were distributed among the various grades as follows: Poloxamer 68, Poloxamer 88, Poloxamer 98, Poloxamer 108, Poloxamer 124, Poloxamer 188, Poloxamer 237, Poloxamer 338, and Poloxamer 407.
Poloxamer 68’s leading market share can be attributed to its extensive application in the pharmaceutical and personal care industries. The high demand for this grade is driven by its exceptional properties, including solubility and emulsification, which are critical in formulations requiring stability and efficacy. The versatility of Poloxamer 68 in various formulations, such as creams, gels, and ointments, further strengthens its market presence.
Following Poloxamer 68, Poloxamer 188 and Poloxamer 407 also hold significant shares in the market, contributing to the overall growth of the Poloxamer segment. Poloxamer 188 is widely utilized in drug delivery systems and biopharmaceutical applications due to its biocompatibility and low toxicity. Poloxamer 407, known for its thermoreversible gelation properties, is extensively used in topical and transdermal drug delivery systems, enhancing the absorption and bioavailability of active ingredients.
The rising awareness regarding the benefits of poloxamers in medical and cosmetic applications has fueled the demand across different grades. Poloxamer 98, Poloxamer 108, and Poloxamer 124, although holding smaller market shares compared to Poloxamer 68, have shown steady growth due to their specialized uses in industrial and laboratory settings.
By Method Analysis
Direct solubilization is the leading method, accounting for 44.7% of the market share in solubilization techniques.
In 2023, Direct Solubilization held a dominant market position by Method segment of the Poloxamer Market, capturing more than a 44.7% share. The market values were distributed among the various methods as follows: Direct Solubilization, Thin Film methods, and Temperature-induced emulsification.
The predominance of Direct Solubilization in the Poloxamer Market is largely attributed to its simplicity and efficiency in application. This method is favored for its ability to rapidly dissolve poloxamers in various solvents without requiring complex processing steps. The ease of use and cost-effectiveness of Direct Solubilization make it an attractive option for manufacturers, particularly in the pharmaceutical and cosmetic industries where quick and reliable solubilization is essential.
Thin Film methods, while holding a smaller share compared to Direct Solubilization, have demonstrated significant utility in specialized applications. This method is particularly valued for its ability to create uniform, thin layers of poloxamers, which are essential in drug delivery systems and advanced coating technologies. The precision and control offered by Thin Film methods contribute to its steady market growth.
Temperature-induced emulsification, although representing a niche segment, plays a critical role in applications where controlled release and stability of formulations are paramount. This method exploits the unique thermoreversible properties of poloxamers, enabling the formation of stable emulsions that are responsive to temperature changes. Its application is particularly prominent in the development of innovative drug delivery systems and topical formulations.
The dominance of Direct Solubilization reflects the market’s preference for methods that offer straightforward implementation and cost efficiency. The continued demand for poloxamers across various industries ensures the relevance of all three methods, each catering to specific application needs. The ongoing advancements in solubilization technologies and increasing focus on efficient formulation processes are expected to sustain the growth and diversification of the Poloxamer Market’s method segment.
By Application Analysis
Biotechnological activity dominates application usage, with a market share of 47.1% in this sector.
In 2023, Biotechnological Activity held a dominant market position by Application segment of the Poloxamer Market, capturing more than a 47.1% share. The market values were distributed among the various applications as follows: Biotechnological Activity, Brain Injury Treatment, DNA Delivery, Microbiological Activity, Cardiovascular Treatment, and Others.
The predominance of Biotechnological Activity in the Poloxamer Market is driven by the expanding scope of biotechnology applications in drug formulation and delivery systems. Poloxamers are widely utilized for their unique properties, such as biocompatibility and non-toxicity, making them ideal for use in various biotechnological processes. Their ability to enhance the solubility and stability of bioactive compounds has been pivotal in the development of advanced therapeutics and biopharmaceuticals.
Brain Injury Treatment follows as a significant application area, leveraging poloxamers’ capacity to facilitate neuroprotective drug delivery. The development of treatments for traumatic brain injuries and neurological disorders has benefited from poloxamers’ ability to cross the blood-brain barrier, thereby improving drug efficacy and patient outcomes.
DNA Delivery, another crucial segment, utilizes poloxamers to enhance the delivery and expression of genetic material. The versatility of poloxamers in forming micelles and nanoparticles makes them suitable carriers for DNA and RNA molecules, promoting advancements in gene therapy and genetic research.
Microbiological Activity and Cardiovascular Treatment also represent important applications, albeit with smaller market shares. In microbiological activity, poloxamers are employed in antimicrobial formulations, while in cardiovascular treatment, they assist in the delivery of drugs targeting heart diseases and related conditions.
The ‘Others’ category encompasses a variety of niche applications where poloxamers are used in smaller but significant capacities, including wound healing and ophthalmic preparations.
By End-Use Analysis
The pharmaceutical industry is the primary end-user, comprising 45.3% of the total market share.
In 2023, the Pharmaceutical Industry held a dominant market position by End-Use segment of the Poloxamer Market, capturing more than a 45.3% share. The market values were distributed among the various end-use segments as follows: Pharmaceutical Industry, Biotechnological Companies, Research Centers, and Others.
The leadership of the Pharmaceutical Industry in the Poloxamer Market is primarily due to the extensive application of poloxamers in drug formulation and delivery. Poloxamers are widely used as solubilizing agents, emulsifiers, and stabilizers in various pharmaceutical formulations, including tablets, creams, gels, and injectables. Their non-toxic and biocompatible properties make them essential in enhancing the bioavailability and efficacy of drugs, driving their widespread adoption in the pharmaceutical sector.
Biotechnological Companies follow closely, leveraging poloxamers for their unique capabilities in the development of advanced therapeutics and biopharmaceutical products. Poloxamers play a critical role in biotechnology applications such as cell culture, protein purification, and the formulation of biologics. Their ability to stabilize proteins and enhance the solubility of bioactive compounds underpins their significant market share in this segment.
Research Centers represent another vital end-use segment, utilizing poloxamers in various experimental and developmental studies. Poloxamers are employed in research for their versatile properties, aiding in the investigation of drug delivery systems, gene therapy, and other innovative medical treatments. The ongoing research activities and the continuous exploration of poloxamers’ potential contribute to the steady growth of this segment.
The ‘Others’ category includes a range of applications where poloxamers are used in smaller but impactful capacities, such as in the cosmetic and personal care industries for product formulations.
Key Market Segments
By Grade
- Poloxamer 68
- Poloxamer 88
- Poloxamer 98
- Poloxamer 108
- Poloxamer 124
- Poloxamer 188
- Poloxamer 237
- Poloxamer 338
- Poloxamer 407
By Method
- Direct Solubilization
- Thin Film methods
- Temperature-induced emulsification
By Application
- Biotechnological Activity
- Brain Injury Treatment
- DNA Delivery
- Microbiological Activity
- Cardiovascular Treatment
- Others
By End-Use
- Pharmaceutical Industry
- Biotechnological Companies
- Research Centers
- Others
Growth Opportunities
Technological Advancements in Poloxamer Formulations
The global Poloxamer market in 2023 has witnessed substantial growth opportunities driven by technological advancements in poloxamer formulations. Innovations in drug delivery systems have prominently utilized poloxamers for their surfactant properties, enhancing drug solubility and bioavailability.
The development of advanced poloxamer formulations has enabled more efficient delivery mechanisms in pharmaceuticals, thereby expanding their application scope. Additionally, the advent of novel poloxamer-based hydrogels and nanogels has further diversified their use in medical and cosmetic applications, offering superior stability and controlled release properties.
These technological advancements not only improve product efficacy but also drive demand in various sectors, including pharmaceuticals, personal care, and biotechnology. Consequently, companies investing in research and development of innovative poloxamer formulations are poised to capture significant market share, benefitting from enhanced product differentiation and increased consumer acceptance.
Eco-friendly Production Methods
The shift towards eco-friendly production methods presents another significant opportunity for the global Poloxamer market in 2023. Increasing environmental regulations and consumer awareness regarding sustainable practices have compelled manufacturers to adopt greener production techniques.
The utilization of renewable resources and environmentally benign processes in poloxamer synthesis reduces the carbon footprint and aligns with global sustainability goals. Eco-friendly production methods not only enhance the marketability of poloxamers but also appeal to environmentally-conscious consumers and industries.
Moreover, the implementation of sustainable practices can lead to cost savings in the long term by reducing waste and energy consumption. As industries across the board prioritize sustainability, poloxamer manufacturers adopting eco-friendly methods are likely to experience heightened demand and improved market positioning. This strategic alignment with global sustainability trends underscores the potential for significant growth and innovation within the poloxamer market.
Latest Trends
Expanding Need for Stable Formulations in Cosmetics
In 2023, the global Poloxamer market has observed a significant trend toward the expanding need for stable formulations in the cosmetics industry. Poloxamers, known for their surfactant and emulsifying properties, are increasingly utilized to enhance the stability and performance of cosmetic products. Their ability to maintain consistency and efficacy under varying conditions has made them indispensable in the formulation of skincare and haircare products.
This trend is driven by consumer demand for high-quality, long-lasting cosmetic products that deliver reliable results. Additionally, poloxamers contribute to the development of innovative textures and sensory experiences, further boosting their popularity among cosmetic manufacturers. As the beauty industry continues to innovate, the demand for stable, versatile ingredients like poloxamers is expected to grow, providing substantial market opportunities.
Versatility of Poloxamers in Various Applications
The versatility of poloxamers has emerged as a key trend in the global Poloxamer market in 2023, broadening their application scope across multiple industries. Beyond their established use in pharmaceuticals and cosmetics, poloxamers are finding new applications in biotechnology, food and beverages, and industrial processes. In biotechnology, poloxamers are employed in cell culture media and as stabilizers in protein formulations, enhancing research and development capabilities. In the food industry, they serve as emulsifiers and solubilizers, improving the texture and stability of food products.
Moreover, poloxamers are used in industrial processes for their lubricating and dispersing properties, aiding in the production of coatings, adhesives, and other materials. This versatility underscores the adaptability of poloxamers to various functional requirements, driving their demand and market growth. As industries increasingly recognize the multifunctional benefits of poloxamers, their market potential continues to expand, reflecting a robust trend toward diversified applications.
Regional Analysis
The North American Poloxamer market holds 46.3%, valued at US$ 13.0 billion, highlighting significant regional dominance in 2023.
The global Poloxamer market is witnessing significant regional variations, driven by differing industrial applications, regulatory landscapes, and economic conditions across North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.
North America emerges as the dominant region, accounting for 46.3% of the global market share, with a valuation of approximately US$ 13.0 billion. This dominance is attributed to the high demand for Poloxamers in the pharmaceutical and personal care industries, particularly in the United States, where stringent regulations and advanced research facilities further bolster market growth. The presence of key market players and significant investments in R&D activities also contribute to North America’s leading position.
In Europe, the Poloxamer market is driven by robust pharmaceutical and cosmetic industries, with countries such as Germany, France, and the UK leading in terms of consumption and production. The region benefits from a well-established regulatory framework that promotes the use of high-quality Poloxamers, ensuring product safety and efficacy. Additionally, the rising trend of sustainable and bio-based products in Europe supports market growth.
Asia Pacific is poised for substantial growth due to increasing industrialization, urbanization, and expanding healthcare and personal care sectors in countries like China, India, and Japan. The region’s large population base and improving economic conditions create a lucrative market for Poloxamers, driven by rising consumer awareness and demand for quality healthcare and personal care products.
The Middle East & Africa region, though relatively smaller in market share, is gradually gaining traction due to the growing pharmaceutical sector and increasing adoption of advanced healthcare solutions. Countries such as the UAE and South Africa are key contributors to market growth in this region.
Latin America also shows promising growth potential, with Brazil and Mexico being the major markets. The region’s developing economies and increasing investments in the pharmaceutical and cosmetic industries are key factors driving the Poloxamer market.
Key Regions and Countries
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Key Players Analysis
In 2023, the global Poloxamer market witnessed a dynamic landscape with several key players driving innovation, competition, and market growth. Among the prominent contenders, BASF emerged as a pivotal force, exerting a significant influence on market dynamics and shaping industry trends. Renowned for its commitment to research and development, BASF stands as a beacon of excellence within the Poloxamer sector.
BASF’s strategic prowess, coupled with its extensive portfolio of Poloxamer-based products, positions the company as a frontrunner in the market. Leveraging its robust distribution network and collaborative partnerships, BASF continues to penetrate diverse application segments, catering to the evolving needs of industries ranging from pharmaceuticals to personal care.
Anshul Life Sciences, another noteworthy player, underscores the competitive landscape with its innovative product offerings and emphasis on quality assurance. With a focus on sustainable practices and stringent regulatory compliance, Anshul Life Sciences exemplifies resilience and adaptability in an ever-evolving market environment.
DeWolf Chemicals, Solvay, and Sirion Biotech GmbH further enrich the competitive milieu, each contributing unique expertise and capabilities to the Poloxamer domain. These companies exemplify a commitment to excellence, driving advancements in product development, manufacturing processes, and customer-centric solutions.
Moreover, the collective efforts of BioPharm International, Sigma-Aldrich, Planet Science, SpecialChem, and other key players underscore a collaborative spirit aimed at fostering industry growth and innovation. Through synergistic partnerships and strategic initiatives, these entities catalyze market expansion while ensuring sustainability and regulatory compliance.
As the Poloxamer market continues to evolve, these key players remain pivotal in shaping its trajectory, driving innovation, and meeting the dynamic demands of global industries. Their collective contributions underscore a landscape characterized by ingenuity, resilience, and a shared commitment to advancing the boundaries of Poloxamer applications.
Market Key Players
- BASF
- Anshul Life Sciences
- DeWolf Chemicals
- Solvay
- Sirion Biotech Gmbh
- BioPharm International
- Sigma-Aldrich
- Planet Science
- SpecialChem
- Others
Recent Development
- In March 2024, BASF, a leading chemical producer, declares Force Majeure for polyamide supplies, impacting North American sales. Uncertain duration prompts sales allocations. The company explores mitigation strategies amid supply chain disruptions.
- In December 2017, Merck, in collaboration with customers, developed a well-characterized Poloxamer 188 for biopharma applications, ensuring consistent quality and cell culture media performance. Orthogonal methods were validated to identify variability, leading to enhanced supply chain transparency and improved customer satisfaction.
Report Scope
Report Features Description Market Value (2023) USD 31.6 Billion Forecast Revenue (2033) USD 59.9 Billion CAGR (2024-2033) 6.6% Base Year for Estimation 2023 Historic Period 2018-2023 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered By Grade(Poloxamer 68, Poloxamer 88, Poloxamer 98, Poloxamer 108, Poloxamer 124, Poloxamer 188, Poloxamer 237, Poloxamer 338, Poloxamer 407), By Method(Direct Solubilization, Thin Film methods, Temperature-induced emulsification), By Application(Biotechnological Activity, Brain Injury Treatment, DNA Delivery, Microbiological Activity, Cardiovascular Treatment, Others), By End-Use(Pharmaceutical Industry, Biotechnological Companies, Research Centers, Others) Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape BASF, Anshul Life Sciences, DeWolf Chemicals, Solvay, Sirion Biotech Gmbh, BioPharm International, Sigma-Aldrich, Planet Science, SpecialChem, Others Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) Frequently Asked Questions (FAQ)
What is the size of the Global Poloxamer Market Size in 2023?The Global Poloxamer Market Size is USD 31.6 Billion in 2023.
What is the projected CAGR at which the Global Poloxamer Market is expected to grow at?The Global Poloxamer Market is expected to grow at a CAGR of 6.6% (2024-2033).
List the segments encompassed in this report on the Global Poloxamer Market?Market.US has segmented the Global Poloxamer Market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Grade(Poloxamer 68, Poloxamer 88, Poloxamer 98, Poloxamer 108, Poloxamer 124, Poloxamer 188, Poloxamer 237, Poloxamer 338, Poloxamer 407), By Method(Direct Solubilization, Thin Film methods, Temperature-induced emulsification), By Application(Biotechnological Activity, Brain Injury Treatment, DNA Delivery, Microbiological Activity, Cardiovascular Treatment, Others), By End-Use(Pharmaceutical Industry, Biotechnological Companies, Research Centers, Others)
List the key industry players of the Global Poloxamer Market?BASF, Anshul Life Sciences, DeWolf Chemicals, Solvay, Sirion Biotech Gmbh, BioPharm International, Sigma-Aldrich, Planet Science, SpecialChem, Others
Name the key areas of business for Global Poloxamer Market?The US, Canada, Mexico are leading key areas of operation for Global Poloxamer Market.
- BASF SE Company Profile
- Anshul Life Sciences
- DeWolf Chemicals
- Solvay
- Sirion Biotech Gmbh
- BioPharm International
- Sigma-Aldrich
- Planet Science
- SpecialChem
- Others
- settingsSettings
Our Clients
Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |